Satsuma Pharmaceuticals Inc. (NASDAQ:STSA) Relative Strength Index (RSI) is 60.42, with weekly volatility at 8.74% and ATR at 0.36. The STSA stock’s 52-week price range
Satsuma’s STS101 did not achieve statistical significance on the co-primary endpoints in Phase 3 EMERGE trials after which STSA plunged almost 76%. The moment Satsuma
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne
